Elsevier Inc.

SHERPA: Unknown

People

  1. Palomba
    Palomba
  2. Dahi
    Dahi
  3. Devlin
    Devlin
  4. Perales
    Perales
  5. Scordo
    Scordo
  6. Shah
    Shah
  7. Shouval
    Shouval
  8. Giralt
    Giralt
  9. Lin
    Lin
  10. Salles
    Salles

Groups

  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies, Division of (9)
  4. Lymphoma (9)
  5. Sloan Kettering Institute Postdocs (9)
  6. Graduate Medical Education (7)
  7. Biostatistics Service (6)
  8. Epidemiology and Biostatistics (6)
  9. Survivorship Research (6)
  10. CTCR Scholars (5)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Sloan Kettering Institute Postdocs"
  3. "Maria Palomba"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies, Division of (9)
  4. Lymphoma (9)
  5. Sloan Kettering Institute Postdocs (9)
  6. Graduate Medical Education (7)

More Groups

People
  1. Maria Palomba (9)
  2. Connie Batlevi (6)
  3. Ana Alarcon Tomas (4)
  4. Anna Alperovich (4)
  5. Craig Sauter (4)
  6. Gunjan Shah (4)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2020 (1)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (1)

More Years

Publications
  1. Transplantation and Cellular Therapy (3)
  2. Best Practice and Research: Clinical Haematology (1)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. European Journal of Cancer (1)
  6. Hematology/Oncology Clinics of North America (1)

More Publications

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Journal Article

    Nath, K.; Tomas, A. A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. L.; Dahi, P. B.; Fingrut, W. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Vitamin D deficiency is associated with inferior clinical outcomes in patients with large B-cell lymphoma receiving anti-CD19 CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Alarcon Tomas, A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. W.; Dahi, P. B.; Fingrut, W.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Gerecitano, J. F.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • First-generation and second-generation Bruton tyrosine kinase inhibitors in Waldenström macroglobulinemia
    Journal Article

    Argyropoulos, K. V.; Lia, M.
    Hematology/Oncology Clinics of North America (2018)

    Fulltext@MSK | Save
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era treated at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P.; Horwitz, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Future therapeutic options for patients with Waldenström macroglobulinemia
    Journal Article

    Castillo, J. J.; Hunter, Z. R.; Yang, G.; Argyropoulos, K.; Palomba, M. L.; Treon, S. P.
    Best Practice and Research: Clinical Haematology (2016)

    Fulltext@MSK | Save
  • TRAIL/DR5 interactions are important for mediating thymic damage after allogeneic bone marrow transplantation
    Meeting Abstract

    Lu, S. X.; Na, I. K.; Yim, N.; Goldberg, G. L.; Tsai, J.; Rao, U. K.; Smith, M.; King, C. G.; Suh, D.; Hirschorn-Cymerman, D.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save